,18,19 In recent years, PD-L1 has emerged as a crucial target for tumor immunotherapy and has been widely applied in the treatment of various tumors, such as non-small cell lung cancer, melanoma, renal cell carcinoma, and gastric cancer, achieving certain clinical efficacy.22 This evidence concerns the gene CD274 and hereditary clear cell renal cell carcinoma.